Making news

Events & publications

March 29, 2022

Tranquis Therapeutics presents at the Stifel CNS Days 2022

February 14-16, 2022

Tranquis Therapeutics presents at the 2022 Bio CEO & Investor Forum

November 12, 2021

ALS News Today: TQS-168 Found to Reduce Inflammation, Extend Survival in Mice

November 8, 2021

The small molecule myeloid cell modulator TQS 168 normalizes the inflammatory phenotype of immune cells from ALS patients and extends survival in the SOD1*G93A ALS mouse model
E. Chavez Juan, D. Ness, B. Ajami, N. Schwartz, J. Hannestad, S. Kakkar and H. Lancero. Presented at Neuroscience, November 8-11, 2021.

November 17, 2020

Fireside Chat with Mike Ward of Decision Resources and CEO Sanjay Kakkar